Oatmealhealth logo

Oatmealhealth

Paid

Empowering Health Equity Through AI-Driven Cancer Screening

5.0
HealthcareContact
#AI-driven platform#health equity#cancer screening#early detection#Federally Qualified Health Center#primary care support#radiology risk assessments#AI innovations#biotech innovations#early diagnosis#healthcare stakeholders#disparities#cancer care continuum#underrepresented communities
Inputs: imageOutputs: text
Type
Saas
Founded
2022
Company
Oatmeal Health
Oatmealhealth screenshot

About Oatmealhealth

Oatmeal Health is an AI-enabled cancer screening service that uses cutting-edge technology to identify, preventively screen, and rescreen vulnerable populations for lung cancer. The service is designed to support Federally Qualified Health Centers (FQHCs), payers, and employers in their mission to improve patient outcomes and reduce healthcare costs. By leveraging AI and machine learning, Oatmeal Health can detect cancer before it worsens, helping to ensure that healthcare costs are minimized and patient compliance is increased. With Oatmeal Health, FQHCs, payers, and employers can proactively identify and screen those at high risk for lung cancer, allowing for early detection and prevention. The service also provides an efficient way to rescreen patients with a history of cancer to make sure that their health remains stable. And its easy-to-use interface makes it simple for healthcare providers to quickly assess patient risks and take appropriate action.

Key Features

AI-driven cancer screening
Focus on underserved FQHC patient populations
Expert primary care support
Comprehensive radiology risk assessments
Cutting-edge AI and biotech advancements
Local nurse and radiologist support
No cost to clinics for additional staff support
Partnerships with a variety of healthcare stakeholders
Reduces disparities in cancer care
Ensures early diagnosis for improved health outcomes

Pros & Cons

Pros
  • Provides a continuous risk score instead of categorical Lung-RADS, potentially offering finer granularity
  • Designed to integrate into existing CADe viewer workflows, reducing implementation friction
  • Focus on underserved populations aligns with health equity goals
  • Prior scan comparison is built-in, aiding longitudinal assessment
  • Reported performance metrics (AUROC 0.96, 94% sensitivity, ~88% specificity) suggest strong accuracy in retrospective testing
  • CPT 0721T reimbursement code availability, though users should verify current FDA clearance status
Cons
  • Pricing is not publicly listed and requires contacting sales; free tier or trial availability not indicated
  • Requires integration with existing CT scanning equipment and CADe viewer, which may involve additional IT costs
  • Platform appears currently focused on lung cancer screening; other cancer types may not be supported without further development
  • Dependence on high-quality CT scan data and prior scans; performance may vary outside of training populations
  • Relies on FDA clearance for full clinical deployment and reimbursement; status should be verified with the company

Best For

Community Health Centers: Enhance cancer screening capabilities and ensure early diagnosis for underserved patients.Rural Health Clinics: Improve access to quality cancer screening and care for patients in remote areas.Health Systems: Collaborate to reduce cancer care disparities across the continuum.Biotech Companies: Partner to integrate advanced AI and biotech solutions in cancer screening.Pharmaceutical Companies: Engage in initiatives that support early cancer detection in underserved populations.Therapeutic Companies: Work together to bring innovative screening technology to at-risk communities.Health Plans: Include cutting-edge cancer screening technologies in healthcare offerings.Medical Device Companies: Collaborate to provide advanced cancer screening tools to underserved areas.Local Healthcare Providers: Receive additional support from Oatmeal Health’s team to manage cancer screenings.Underserved Patient Populations: Benefit from early cancer detection and comprehensive care services.

Alternatives to Oatmealhealth

FAQ

What is LungAI?
LungAI is a deep learning-based computer-aided diagnosis (CADx) system that provides radiologists with a continuous malignancy risk score (0–100) for each lung nodule, integrated into existing CADe viewers. It is designed to improve early detection of lung cancer.
Is Oatmeal Health FDA cleared?
LungAI is pending FDA 510(k) clearance and is not yet FDA-cleared or commercially available. The company expects clearance in early 2027. All clinical performance data reflect retrospective studies on held-out datasets.
How does Oatmeal Health identify eligible patients?
The platform mines EHR data to identify patients with 20+ pack-year smoking histories, even when that information is buried in clinical notes and not entered into structured fields. It then uses AI-powered voice callers and nurse navigators to reach and educate patients.
What is the CPT code associated with Oatmeal Health's platform?
CPT 0721T is a reimbursable code for AI-based lung cancer screening services, available under the hospital outpatient setting following FDA clearance.
Who founded Oatmeal Health?
Oatmeal Health was co-founded in 2022 in Mountain View, CA by Jonathan Govette (CEO), Yuri Ahuja MD PhD, and Ashish Basuray PhD. Govette started the company after losing multiple family members to cancer.